跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
endoxifen
首页
药物
endoxifen
endoxifen
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
METHODS FOR MAKING AND USING ENDOXIFEN
EP 3681491 A1
申请人: ATOSSA THERAPEUTICS INC
优先权: 2017
CN
EP
US
WO
22 件公开
SUSTAINED RELEASE COMPOSITIONS OF ENDOXIFEN
US 2022175702 A1
申请人: ATOSSA THERAPEUTICS INC
优先权: 2020
EP
US
4 件公开
ENDOXIFEN FOR THE TREATMENT OF BIPOLAR I DISORDER
EP 4132498 A4
申请人: JINA PHARMACEUTICALS INC
优先权: 2020
EP
US
WO
3 件公开
EP 4132497 A4
申请人: JINA PHARMACEUTICALS INC
优先权: 2020
EP
US
WO
3 件公开
ENDOXIFEN FOR TREATMENT OF OVARIAN CANCER
EP 4304574 A4
申请人: ATOSSA THERAPEUTICS INC
优先权: 2021
EP
US
WO
3 件公开
ENDOXIFEN COMPOSITIONS AND METHODS OF USE THEREOF AND SYNTHESIS THEREOF
EP 4746863 A1
申请人: ATOSSA THERAPEUTICS INC
优先权: 2023
EP
US
WO
3 件公开
Endoxifen compositions and methods
US 9333190 B2
申请人: AHMAD ATEEQ
优先权: 2007
US
3 件公开
TRANSDERMAL PHARMACEUTICAL COMPOSITIONS COMPRISING A SERM
EP 3656376 A1
申请人: BESINS HEALTHCARE LU SARL
优先权: 2008
EP
US
2 件公开
ORAL FORMULATIONS OF (Z)-ENDOXIFEN AND METHODS OF USE THEREOF
WO 2025137145 A1
申请人: ATOSSA THERAPEUTICS INC
优先权: 2023
CN
WO
2 件公开
ENDOXIFEN FOR TREATMENT OF RARE CANCERS
WO 2025151443 A1
申请人: ATOSSA THERAPEUTICS INC
优先权: 2024
CN
WO
2 件公开
ENDOXIFEN METHODS AND COMPOSITIONS IN THE TREATMENT OF PSYCHIATRIC AND NEURODEGENERATIVE DISEASES
US 2009291134 A1
申请人: JINA PHARMACEUTICALS INC
优先权: 2009
US
2 件公开
第 1 / 3 页
上一页
下一页
药物
反馈